Taubman Emerging Scholar Katherine A. Gallagher, MD, has been elected to the prestigious National Academy of Medicine (NAM), the highest honorary society in the country for researchers in the fields of health and medicine.
Dr. Gallagher, who received Taubman Institute funding for her early research into the mechanisms of impaired wound healing in patients with diabetes. She is recognized by the NAM for her innovative translational research on epigenetic regulation of immune cells during normal and pathologic tissue repair and other cardiovascular disease processes.
At the U-M medical school, Dr. Gallagher serves as professor of surgery, professor of microbiology and immunology and the John R. Pfeifer Professor of Surgery. She also is the vice chair of basic and translational science and an exceptionally well-funded researcher supported by multiple R01s and other foundational grants, including the Doris Duke Charitable Foundation and Wylie Scholars, among others. She is an expert in the molecular pathogenesis of wound repair and has contributed substantially to the understanding of epigenetics in immune cells associated with tissue repair, cardiovascular diseases, sepsis and most recently, COVID-19.
Dr. Gallagher was appointed a Taubman Emerging Scholar in 2012.
